Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global active pharmaceutical ingredients (API) market size reached US$ 209.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 291.7 Billion by 2027, exhibiting a growth rate (CAGR) of 5.46% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as 'excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global active pharmaceutical ingredients (API) market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug type, type of manufacturer, type of synthesis and therapeutic application.
Breakup by Drug Type:
Innovative Active Pharmaceutical Ingredients (API)
Generic Active Pharmaceutical Ingredients (API)
Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.
Breakup by Type of Manufacturer:
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
Breakup by Type of Synthesis:
Synthetic Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Transgenic Animal Systems
Others
Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
Breakup by Therapeutic Application:
Oncology
Cardiovascular and Respiratory
Diabetes
Central Nervous System Disorders
Neurological Disorders
Others
Based on the therapeutic application, the market has been segmented as oncology, cardiovascular & respiratory, diabetes, central nervous system disorders, neurological disorders and others.
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Middle East and Africa
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the (active pharmaceutical ingredients companies) key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Key Questions Answered in This Report:
How has the global active pharmaceutical ingredients (API) market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global active pharmaceutical ingredients (API) industry?
What are the key regional markets in the global active pharmaceutical ingredients (API) industry?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of drug type?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of type of manufacturer?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of type of synthesis?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of therapeutic application?
What are the various stages in the value chain of the global active pharmaceutical ingredients (API) market?
What are the key driving factors and challenges in the global active pharmaceutical ingredients (API) market?
What is the structure of the global active pharmaceutical ingredients (API) market and who are the key players?
What is the degree of competition in the global active pharmaceutical ingredients (API) market?
How are active pharmaceutical ingredients (API) manufactured?
Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as 'excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global active pharmaceutical ingredients (API) market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug type, type of manufacturer, type of synthesis and therapeutic application.
Breakup by Drug Type:
Innovative Active Pharmaceutical Ingredients (API)
Generic Active Pharmaceutical Ingredients (API)
Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.
Breakup by Type of Manufacturer:
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
Breakup by Type of Synthesis:
Synthetic Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients (API)
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Transgenic Animal Systems
Others
Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
Breakup by Therapeutic Application:
Oncology
Cardiovascular and Respiratory
Diabetes
Central Nervous System Disorders
Neurological Disorders
Others
Based on the therapeutic application, the market has been segmented as oncology, cardiovascular & respiratory, diabetes, central nervous system disorders, neurological disorders and others.
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Middle East and Africa
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the (active pharmaceutical ingredients companies) key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Key Questions Answered in This Report:
How has the global active pharmaceutical ingredients (API) market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global active pharmaceutical ingredients (API) industry?
What are the key regional markets in the global active pharmaceutical ingredients (API) industry?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of drug type?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of type of manufacturer?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of type of synthesis?
What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of therapeutic application?
What are the various stages in the value chain of the global active pharmaceutical ingredients (API) market?
What are the key driving factors and challenges in the global active pharmaceutical ingredients (API) market?
What is the structure of the global active pharmaceutical ingredients (API) market and who are the key players?
What is the degree of competition in the global active pharmaceutical ingredients (API) market?
How are active pharmaceutical ingredients (API) manufactured?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Drug Type
5.5 Market Breakup by Type of Manufacturer
5.6 Market Breakup by Type of Synthesis
5.7 Market Breakup by Therapeutic Application
5.8 Market Breakup by Region
5.9 Market Forecast
5.10 SWOT Analysis
5.10.1 Overview
5.10.2 Strengths
5.10.3 Weaknesses
5.10.4 Opportunities
5.10.5 Threats
5.11 Value Chain Analysis
5.12 Porters Five Forces Analysis
5.12.1 Overview
5.12.2 Bargaining Power of Buyers
5.12.3 Bargaining Power of Suppliers
5.12.4 Degree of Competition
5.12.5 Threat of New Entrants
5.12.6 Threat of Substitutes
5.13 Price Analysis
5.13.1 Price Indicators
5.13.2 Price Structure
6 MARKET BREAKUP BY DRUG TYPE
6.1 Innovative Active Pharmaceutical Ingredients (API)
6.2 Generic Active Pharmaceutical Ingredients (API)
7 MARKET BREAKUP BY TYPE OF MANUFACTURER
7.1 Captive Manufacturers
7.2 Merchant API Manufacturers
7.2.1 Innovative Merchant API Manufacturers
7.2.2 Generic Merchant API Manufacturers
8 MARKET BREAKUP BY TYPE OF SYNTHESIS
8.1 Synthetic Active Pharmaceutical Ingredients (API)
8.1.1 Market Breakup by Type
8.1.1.1 Innovative Synthetic APIs
8.1.1.2 Generic Synthetic APIs
8.2 Biotech Active Pharmaceutical Ingredients (API)
8.2.1 Market Breakup by Type
8.2.1.1 Innovative Biotech APIs
8.2.1.2 Biosimilars
8.2.2 Market Breakup by Product
8.2.2.1 Monoclonal Antibodies
8.2.2.2 Vaccines
8.2.2.3 Cytokines
8.2.2.4 Fusion Proteins
8.2.2.5 Therapeutic Enzymes
8.2.2.6 Blood Factors
8.2.3 Market Breakup by Expression System
8.2.3.1 Mammalian Expression Systems
8.2.3.2 Microbial Expression Systems
8.2.3.3 Yeast Expression Systems
8.2.3.4 Transgenic Animal Systems
8.2.3.5 Others
9 MARKET BREAKUP BY THERAPEUTIC APPLICATION
9.1 Oncology
9.2 Cardiovascular and Respiratory
9.3 Diabetes
9.4 Central Nervous System Disorders
9.5 Neurological Disorders
9.6 Others
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Others
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Others
10.4 Latin America
10.5 Middle East and Africa
11 API MANUFACTURING PROCESS
11.1 Product Overview
11.2 Raw Material Requirements
11.3 Manufacturing Process
11.4 Key Success and Risk Factors
12 COMPETITIVE LANDSCAPE
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
12.3.1 Pfizer, Inc.
12.3.2 Novartis International AG
12.3.3 Sanofi
12.3.4 Boehringer Ingelheim
12.3.5 Bristol-Myers Squibb
12.3.6 Teva Pharmaceutical Industries Ltd.
12.3.7 ELI Lilly and Company
12.3.8 GlaxoSmithKline
12.3.9 Merck & Co., Inc.
12.3.10 Abbvie Inc
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Drug Type
5.5 Market Breakup by Type of Manufacturer
5.6 Market Breakup by Type of Synthesis
5.7 Market Breakup by Therapeutic Application
5.8 Market Breakup by Region
5.9 Market Forecast
5.10 SWOT Analysis
5.10.1 Overview
5.10.2 Strengths
5.10.3 Weaknesses
5.10.4 Opportunities
5.10.5 Threats
5.11 Value Chain Analysis
5.12 Porters Five Forces Analysis
5.12.1 Overview
5.12.2 Bargaining Power of Buyers
5.12.3 Bargaining Power of Suppliers
5.12.4 Degree of Competition
5.12.5 Threat of New Entrants
5.12.6 Threat of Substitutes
5.13 Price Analysis
5.13.1 Price Indicators
5.13.2 Price Structure
6 MARKET BREAKUP BY DRUG TYPE
6.1 Innovative Active Pharmaceutical Ingredients (API)
6.2 Generic Active Pharmaceutical Ingredients (API)
7 MARKET BREAKUP BY TYPE OF MANUFACTURER
7.1 Captive Manufacturers
7.2 Merchant API Manufacturers
7.2.1 Innovative Merchant API Manufacturers
7.2.2 Generic Merchant API Manufacturers
8 MARKET BREAKUP BY TYPE OF SYNTHESIS
8.1 Synthetic Active Pharmaceutical Ingredients (API)
8.1.1 Market Breakup by Type
8.1.1.1 Innovative Synthetic APIs
8.1.1.2 Generic Synthetic APIs
8.2 Biotech Active Pharmaceutical Ingredients (API)
8.2.1 Market Breakup by Type
8.2.1.1 Innovative Biotech APIs
8.2.1.2 Biosimilars
8.2.2 Market Breakup by Product
8.2.2.1 Monoclonal Antibodies
8.2.2.2 Vaccines
8.2.2.3 Cytokines
8.2.2.4 Fusion Proteins
8.2.2.5 Therapeutic Enzymes
8.2.2.6 Blood Factors
8.2.3 Market Breakup by Expression System
8.2.3.1 Mammalian Expression Systems
8.2.3.2 Microbial Expression Systems
8.2.3.3 Yeast Expression Systems
8.2.3.4 Transgenic Animal Systems
8.2.3.5 Others
9 MARKET BREAKUP BY THERAPEUTIC APPLICATION
9.1 Oncology
9.2 Cardiovascular and Respiratory
9.3 Diabetes
9.4 Central Nervous System Disorders
9.5 Neurological Disorders
9.6 Others
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Others
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Others
10.4 Latin America
10.5 Middle East and Africa
11 API MANUFACTURING PROCESS
11.1 Product Overview
11.2 Raw Material Requirements
11.3 Manufacturing Process
11.4 Key Success and Risk Factors
12 COMPETITIVE LANDSCAPE
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
12.3.1 Pfizer, Inc.
12.3.2 Novartis International AG
12.3.3 Sanofi
12.3.4 Boehringer Ingelheim
12.3.5 Bristol-Myers Squibb
12.3.6 Teva Pharmaceutical Industries Ltd.
12.3.7 ELI Lilly and Company
12.3.8 GlaxoSmithKline
12.3.9 Merck & Co., Inc.
12.3.10 Abbvie Inc
LIST OF TABLES
Table 1: Global: Active Pharmaceutical Ingredients (API) Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 3: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2022-2027
Table 4: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Type of Synthesis (in Million US$), 2022-2027
Table 5: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Therapeutic Application (in Million US$), 2022-2027
Table 6: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Active Pharmaceutical Ingredients (API): Raw Material Requirements
Table 8: Active Pharmaceutical Ingredients (API): Equipment Requirements
Table 9: Global: Active Pharmaceutical Ingredients (API) Market: Competitive Structure
Table 10: Global: Active Pharmaceutical Ingredients (API) Market: Key Players
Table 1: Global: Active Pharmaceutical Ingredients (API) Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 3: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2022-2027
Table 4: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Type of Synthesis (in Million US$), 2022-2027
Table 5: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Therapeutic Application (in Million US$), 2022-2027
Table 6: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Active Pharmaceutical Ingredients (API): Raw Material Requirements
Table 8: Active Pharmaceutical Ingredients (API): Equipment Requirements
Table 9: Global: Active Pharmaceutical Ingredients (API) Market: Competitive Structure
Table 10: Global: Active Pharmaceutical Ingredients (API) Market: Key Players
LIST OF FIGURES
Figure 1: Global: Active Pharmaceutical Ingredients (API) Market: Major Drivers and Challenges
Figure 2: Global: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Drug Type (in %), 2021
Figure 4: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Type of Manufacturer (in %), 2021
Figure 5: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Type of Synthesis (in %), 2021
Figure 6: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Therapeutic Application (in %), 2021
Figure 7: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Region (in %), 2021
Figure 8: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Active Pharmaceutical Ingredients (API) Industry: SWOT Analysis
Figure 10: Global: Active Pharmaceutical Ingredients( API) Industry: Value Chain Analysis
Figure 11: Global: Active Pharmaceutical Ingredients (API) Industry: Porter’s Five Forces Analysis
Figure 12: Active Pharmaceutical Ingredients (API) Manufacturing: Price Structure (in %)
Figure 13: Global: Innovative Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Innovative Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Generic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Generic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market: Sales Value (in Billion US$), 2016-2021
Figure 20: Global: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 21: Global: Merchant API Manufacturers Market: Breakup by Type (in %), 2021
Figure 22: Global: Merchant Generic API Manufacturers Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Merchant Generic API Manufacturers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Merchant Innovative API Manufacturers Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Merchant Innovative API Manufacturers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Synthetic Active Pharmaceutical Ingredients (API) Market: Breakup by Type (in %), 2021
Figure 29: Global: Innovative Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Innovative Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Generic Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Generic Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Biotech Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Breakup by Type (in %), 2021
Figure 36: Global: Innovative Biotech Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Innovative Biotech Active Pharmaceutical Ingredients (API) Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Breakup by Product Type (in %), 2021
Figure 41: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System (in %), 2021
Figure 54: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Global: Biotech Active Pharmaceutical Ingredients (Transgenic Animal Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Global: Biotech Active Pharmaceutical Ingredients (Transgenic Animal Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Global: Biotech Active Pharmaceutical Ingredients (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Global: Biotech Active Pharmaceutical Ingredients (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Global: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Global: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Global: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Global: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Global: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Global: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Global: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Global: Active Pharmaceutical Ingredients (Neurological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Global: Active Pharmaceutical Ingredients (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Active Pharmaceutical Ingredients (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Global: Active Pharmaceutical Ingredients (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: North America: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: North America: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: United States: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: United States: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Canada: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Canada: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Europe: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Europe: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Germany: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Germany: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: France: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: France: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: United Kingdom: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: United Kingdom: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Italy: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Italy: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Spain: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Spain: Active Pharmaceutical Ingredients Market (API) Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Russia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Russia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Others: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Others: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Asia Pacific: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Asia Pacific: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: China: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: China: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 102: Japan: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 103: Japan: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 104: India: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 105: India: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 106: South Korea: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 107: South Korea: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 108: Australia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 109: Australia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 110: Indonesia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 111: Indonesia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 112: Others: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 113: Others: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 114: Middle East and Africa: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 115: Middle East and Africa: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 116: Latin America: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 117: Latin America: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 118: API Manufacturing (Chemical Synthesis): Process Flow
Figure 1: Global: Active Pharmaceutical Ingredients (API) Market: Major Drivers and Challenges
Figure 2: Global: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Drug Type (in %), 2021
Figure 4: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Type of Manufacturer (in %), 2021
Figure 5: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Type of Synthesis (in %), 2021
Figure 6: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Therapeutic Application (in %), 2021
Figure 7: Global: Active Pharmaceutical Ingredients (API) Market: Breakup by Region (in %), 2021
Figure 8: Global: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Active Pharmaceutical Ingredients (API) Industry: SWOT Analysis
Figure 10: Global: Active Pharmaceutical Ingredients( API) Industry: Value Chain Analysis
Figure 11: Global: Active Pharmaceutical Ingredients (API) Industry: Porter’s Five Forces Analysis
Figure 12: Active Pharmaceutical Ingredients (API) Manufacturing: Price Structure (in %)
Figure 13: Global: Innovative Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Innovative Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Generic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Generic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market: Sales Value (in Billion US$), 2016-2021
Figure 20: Global: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 21: Global: Merchant API Manufacturers Market: Breakup by Type (in %), 2021
Figure 22: Global: Merchant Generic API Manufacturers Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Merchant Generic API Manufacturers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Merchant Innovative API Manufacturers Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Merchant Innovative API Manufacturers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Synthetic Active Pharmaceutical Ingredients (API) Market: Breakup by Type (in %), 2021
Figure 29: Global: Innovative Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Innovative Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Generic Synthetic Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Generic Synthetic Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Biotech Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Breakup by Type (in %), 2021
Figure 36: Global: Innovative Biotech Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Innovative Biotech Active Pharmaceutical Ingredients (API) Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Biotech Active Pharmaceutical Ingredients (Biosimilars) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Biotech Active Pharmaceutical Ingredients (API) Market: Breakup by Product Type (in %), 2021
Figure 41: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Biotech Active Pharmaceutical Ingredients (Fusion Proteins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Biotech Active Pharmaceutical Ingredients (Therapeutic Enzymes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Biotech Active Pharmaceutical Ingredients (Blood Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System (in %), 2021
Figure 54: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Global: Biotech Active Pharmaceutical Ingredients (Mammalian Expression Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Global: Biotech Active Pharmaceutical Ingredients (Microbial Expression Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Global: Biotech Active Pharmaceutical Ingredients (Yeast Expression Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Global: Biotech Active Pharmaceutical Ingredients (Transgenic Animal Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Global: Biotech Active Pharmaceutical Ingredients (Transgenic Animal Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Global: Biotech Active Pharmaceutical Ingredients (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Global: Biotech Active Pharmaceutical Ingredients (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Global: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Global: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Global: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Global: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Global: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Global: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Global: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Global: Active Pharmaceutical Ingredients (Neurological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Global: Active Pharmaceutical Ingredients (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Active Pharmaceutical Ingredients (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Global: Active Pharmaceutical Ingredients (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: North America: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: North America: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: United States: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: United States: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Canada: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Canada: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Europe: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Europe: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Germany: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Germany: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: France: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: France: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: United Kingdom: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: United Kingdom: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Italy: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Italy: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Spain: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Spain: Active Pharmaceutical Ingredients Market (API) Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Russia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Russia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Others: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Others: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Asia Pacific: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Asia Pacific: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: China: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 101: China: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 102: Japan: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 103: Japan: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 104: India: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 105: India: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 106: South Korea: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 107: South Korea: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 108: Australia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 109: Australia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 110: Indonesia: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 111: Indonesia: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 112: Others: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 113: Others: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 114: Middle East and Africa: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 115: Middle East and Africa: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 116: Latin America: Active Pharmaceutical Ingredients (API) Market: Sales Value (in Million US$), 2016 & 2021
Figure 117: Latin America: Active Pharmaceutical Ingredients (API) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 118: API Manufacturing (Chemical Synthesis): Process Flow
